Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 69 results for "mylan"

US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim
Business Standard

Biocon and Mylan get USFDA approval to jointly develop biologi...

The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace The post Biocon and Mylan get USFDA approval to jointly develop biologic product appeared first on Firstpost . First, 2 days ago

1,764 images for mylan

Business Standard, 2 days ago
SleekMoney, 1 week ago
SleekMoney, 1 week ago, 1 week ago, 1 week ago
CNBC, 1 week ago
CBS News, 2 weeks ago, 2 weeks ago
Money Control, 2 weeks ago
BioSpace, 2 weeks ago

USFDA accepts Mylan's application for proposed biosimilar

It has got acceptance of regulatory filings in Europe, Australia and Canada
 Business Standard3 days ago Biocon scales record high as USFDA accepts BLA for proposed biosimilar Trastuzumab  Business Standard1 month ago USFDA to review Biocon-Mylan's biosimilar drug for breast cancer  Money Control1 month ago Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim  Money Control2 days ago

Biocon chief sees anti-cancer biosimilar launch in FY19

Biocon Thursday announced the US Food and Drug Administration has accepted Mylan’s Biologics License Application (BLA) for biosimilar chemotherapy drug Pegfilgrastim for review. Sharing details on the development with CNBC-TV18 Biocon Chairperson and ...
 Money Control2 days ago US nod for Biocon-Mylan biosimilar  Business Line1 month ago Biosimilar developed by Biocon, Mylan  Business Line1 month ago Biocon proposed Biosimilar developed by Mylan and Company  India Infoline1 month ago

Can Biocon, Mylan drugs be used for early breast cancer: HC

Can pharma majors Biocon and Mylan's generic breast cancer drugs, similar to that of their competitor Roche, be prescribed for early breast cancer and metastatic gastric cancer?
 DNA3 days ago

HC dismisses Sun Pharma's plea against Mylan on Oxaliplatin trademark case

Delhi High Court allows companies to approach bench after IPAB order
 Business Standard1 week ago
Business Line

Natco gets a booster dose on favorable patent ruling in US

Natco and Mylan believe that they are the first companies to have filed a substantially complete abbreviated new drug application containing a Para-IV certification for a 3 times per week Glatiramer Acetate Injection 40 mg/mL, and expect 180 days of marketing ...
 Money Control2 weeks ago Natco Pharma climbs after partner wins patent case in US  DNA2 weeks ago US Court rules in favour of Mylan for Copaxone patents: Natco  DNA2 weeks ago

Natco�s partner Mylan wins US district court ruling related to Copaxone patents

Natco Pharma announced that the United States District Court for the District of Delaware issued a decision finding all asserted claims of four Orange Book-listed patents relating to Copaxone 40 mg/ml invalid based on obviousness.
 Money Control2 weeks ago Natco's partner Mylan wins U.S. district court ruling related to Copaxone 40mg/ml patents  India Infoline2 weeks ago

U.S. states sue Mylan, Teva, others for fixing drug prices

Two years after high generic drug prices became a public controversy, legal cases are starting to land. Twenty states filed a lawsuit Thursday against Mylan NV ( MYL.O ), Teva Pharmaceuticals ( TEVA.TA ) and four other generic drug makers, saying they ...
 Reuters2 months ago Pharma shares tumble as Trump threatens to crackdown on drug prices  Business Standard2 months ago
Money Control

Lupin gets final USFDA nod for Mylan's skin disease cream

Pharma major Lupin today said it has received final approval from the US health regulator to market its generic version of Mylan's triamcinolone acetonide cream used for treatment of skin disease.
 DNA2 weeks ago Lupin receives FDA approval for Triamcinolone Acetonide cream  Money Control2 weeks ago

Mylan says being investigated over EpiPen practices

EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo n">Mylan NV ( MYL.O ) said on Monday U.S. antitrust ...
 Reuters2 weeks ago Mylan launches EpiPen generic at $300 per two-pack  Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less